Clinical Social Workers in Jackson Hts, NY Accepting Medicare
7 Clinical Social Workers found. Showing 1 - 7
 Mr. Julian J Rivera, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Ocni 3764 72nd St, Jackson Hts, NY 11372 Phone: 718-335-3434 Fax: 718-335-4731 |
Mr. Philip John Clancey, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 3764 72nd St, Ocni, Jackson Hts, NY 11372 Phone: 718-335-3434 Fax: 718-335-4731 |
Mr. Gregory L Higgins Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3764 72nd St, Ocni, Jackson Hts, NY 11372 Phone: 718-335-3434 Fax: 718-335-4731 |
Dr. Cesar M Garces, DSW LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3764 72nd St, Ocni, Jackson Hts, NY 11372 Phone: 718-335-3434 Fax: 718-335-4731 |
 Mrs. Ethel Gonzalez, LCSW R Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3424 77th St, Apt#35, Jackson Hts, NY 11372 Phone: 718-898-9615 |
Samantha Bennahum, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3515 75th St Apt 208, Jackson Hts, NY 11372 Phone: 917-837-9194 |
Mr. Cesar R Vera, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: Ocni 37 64 72nd St, Jackson Hts, NY 11372 Phone: 718-335-3434 Fax: 718-335-4731 |
News Archive
Positive results from Jennerex JX-594 proof-of-concept trial on metastatic melanoma
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
Tattoo industry needs closer monitoring
The increased popularity of tattoos is causing a noticable rise in the number of complaints of adverse side effects associated with both their application and removal.
Quantitative capabilities of Helicos' single-molecule sequencing technology demonstrated
Helicos BioSciences Corporation today announced a publication entitled "Amplification-free digital gene expression profiling from minute cell quantities" appearing on line in Nature Methods co-authored by Dr. Daniel A. Haber and colleagues from Massachusetts General Hospital. The paper demonstrates the quantitative capabilities of Helicos' single-molecule sequencing technology and its potential to reveal important genomic differences when minimal numbers of cells are available for analysis.
Researchers find that cancer gene require copper to promote tumor growth
Drugs used to block copper absorption for a rare genetic condition may find an additional use as a treatment for certain types of cancer, researchers at Duke Medicine report.
› Verified 2 days ago